Literature DB >> 27866355

The descriptive epidemiology of DSM-IV Adult ADHD in the World Health Organization World Mental Health Surveys.

John Fayyad1, Nancy A Sampson2, Irving Hwang2, Tomasz Adamowski3, Sergio Aguilar-Gaxiola4, Ali Al-Hamzawi5, Laura H S G Andrade6, Guilherme Borges7, Giovanni de Girolamo8, Silvia Florescu9, Oye Gureje10, Josep Maria Haro11, Chiyi Hu12,13, Elie G Karam14,15,16, Sing Lee17, Fernando Navarro-Mateu18, Siobhan O'Neill19, Beth-Ellen Pennell20, Marina Piazza21,22, José Posada-Villa23, Margreet Ten Have24, Yolanda Torres25, Miguel Xavier26, Alan M Zaslavsky2, Ronald C Kessler2.   

Abstract

We previously reported on the cross-national epidemiology of ADHD from the first 10 countries in the WHO World Mental Health (WMH) Surveys. The current report expands those previous findings to the 20 nationally or regionally representative WMH surveys that have now collected data on adult ADHD. The Composite International Diagnostic Interview (CIDI) was administered to 26,744 respondents in these surveys in high-, upper-middle-, and low-/lower-middle-income countries (68.5% mean response rate). Current DSM-IV/CIDI adult ADHD prevalence averaged 2.8% across surveys and was higher in high (3.6%)- and upper-middle (3.0%)- than low-/lower-middle (1.4%)-income countries. Conditional prevalence of current ADHD averaged 57.0% among childhood cases and 41.1% among childhood subthreshold cases. Adult ADHD was significantly related to being male, previously married, and low education. Adult ADHD was highly comorbid with DSM-IV/CIDI anxiety, mood, behavior, and substance disorders and significantly associated with role impairments (days out of role, impaired cognition, and social interactions) when controlling for comorbidities. Treatment seeking was low in all countries and targeted largely to comorbid conditions rather than to ADHD. These results show that adult ADHD is prevalent, seriously impairing, and highly comorbid but vastly under-recognized and undertreated across countries and cultures.

Entities:  

Keywords:  ADHD; Attention-deficit/hyperactivity disorder; Comorbidity; Disability epidemiology; Impairment; Prevalence; Treatment

Mesh:

Year:  2016        PMID: 27866355      PMCID: PMC5325787          DOI: 10.1007/s12402-016-0208-3

Source DB:  PubMed          Journal:  Atten Defic Hyperact Disord        ISSN: 1866-6116


  54 in total

1.  The effects of lisdexamfetamine dimesylate on the driving performance of young adults with ADHD: a randomized, double-blind, placebo-controlled study using a validated driving simulator paradigm.

Authors:  Joseph Biederman; Ronna Fried; Paul Hammerness; Craig Surman; Bruce Mehler; Carter R Petty; Stephen V Faraone; Carolyn Miller; Michelle Bourgeois; Benjamin Meller; Kathryn M Godfrey; Bryan Reimer
Journal:  J Psychiatr Res       Date:  2012-01-24       Impact factor: 4.791

2.  Attention deficits and divorce.

Authors:  Geneviève Bouchard; Jean Saint-Aubin
Journal:  Can J Psychiatry       Date:  2014-09       Impact factor: 4.356

Review 3.  Gender differences in attention-deficit/hyperactivity disorder.

Authors:  Julia J Rucklidge
Journal:  Psychiatr Clin North Am       Date:  2010-06

4.  Age-dependent decline of attention deficit hyperactivity disorder.

Authors:  J C Hill; E P Schoener
Journal:  Am J Psychiatry       Date:  1996-09       Impact factor: 18.112

5.  Validation of the parent version of the World Health Organization Adult ADHD Self-Report Scale for adolescents.

Authors:  Linda Sjölander; Sofia Vadlin; Susanne Olofsdotter; Karin Sonnby
Journal:  Nord J Psychiatry       Date:  2015-12-01       Impact factor: 2.202

6.  Concordance of the Composite International Diagnostic Interview Version 3.0 (CIDI 3.0) with standardized clinical assessments in the WHO World Mental Health surveys.

Authors:  Josep Maria Haro; Saena Arbabzadeh-Bouchez; Traolach S Brugha; Giovanni de Girolamo; Margaret E Guyer; Robert Jin; Jean Pierre Lepine; Fausto Mazzi; Blanca Reneses; Gemma Vilagut; Nancy A Sampson; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

Review 7.  A systematic review of prospective studies on attention problems and academic achievement.

Authors:  Tinca J C Polderman; D I Boomsma; M Bartels; F C Verhulst; A C Huizink
Journal:  Acta Psychiatr Scand       Date:  2010-06-28       Impact factor: 6.392

Review 8.  Epidemiologic considerations in attention deficit hyperactivity disorder: a review and update.

Authors:  Guilherme Polanczyk; Peter Jensen
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

Review 9.  The Association Between Socioeconomic Disadvantage and Attention Deficit/Hyperactivity Disorder (ADHD): A Systematic Review.

Authors:  Abigail Emma Russell; Tamsin Ford; Rebecca Williams; Ginny Russell
Journal:  Child Psychiatry Hum Dev       Date:  2016-06

Review 10.  Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis.

Authors:  Viktória Simon; Pál Czobor; Sára Bálint; Agnes Mészáros; István Bitter
Journal:  Br J Psychiatry       Date:  2009-03       Impact factor: 9.319

View more
  118 in total

Review 1.  Adult Attention-Deficit/Hyperactivity Disorder (ADHD) and Insomnia: an Update of the Literature.

Authors:  Dora Wynchank; Denise Bijlenga; Aartjan T Beekman; J J Sandra Kooij; Brenda W Penninx
Journal:  Curr Psychiatry Rep       Date:  2017-10-30       Impact factor: 5.285

2.  [ADHD screening in alcohol dependent subjects : Psychometric characteristics of ADHD self-report scale and Wender Utah Rating Scale short form].

Authors:  Mathias Luderer; Nurcihan Kaplan-Wickel; Christian Sick; Agnes Richter; Iris Reinhard; Falk Kiefer; Tillmann Weber
Journal:  Nervenarzt       Date:  2019-11       Impact factor: 1.214

3.  Adult patients with ADHD differ from healthy controls in implicit, but not explicit, emotion regulation

Authors:  Lukas Materna; Christian Dirk Wiesner; Anna Shushakova; Julia Trieloff; Nathalia Weber; Alva Engell; Ricarda I. Schubotz; Jochen Bauer; Anya Pedersen; Patricia Ohrmann
Journal:  J Psychiatry Neurosci       Date:  2019-09-01       Impact factor: 6.186

4.  Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus.

Authors:  Susan Young; Jack Hollingdale; Michael Absoud; Patrick Bolton; Polly Branney; William Colley; Emily Craze; Mayuri Dave; Quinton Deeley; Emad Farrag; Gisli Gudjonsson; Peter Hill; Ho-Lan Liang; Clodagh Murphy; Peri Mackintosh; Marianna Murin; Fintan O'Regan; Dennis Ougrin; Patricia Rios; Nancy Stover; Eric Taylor; Emma Woodhouse
Journal:  BMC Med       Date:  2020-05-25       Impact factor: 8.775

5.  Accident patterns in trauma surgery patients with and without self-reported ADHD.

Authors:  Sarah Wolff; Kristin Queiser; Leonie Wessendorf; Anna Maria Meier; Moritz Verdenhalven; Oliver Grimm; Christoph Reimertz; Christoph Nau; Michelle Klos; Andreas Reif; Sarah Kittel-Schneider
Journal:  J Neural Transm (Vienna)       Date:  2019-05-10       Impact factor: 3.575

6.  Association Between Medication Use and Performance on Higher Education Entrance Tests in Individuals With Attention-Deficit/Hyperactivity Disorder.

Authors:  Yi Lu; Arvid Sjölander; Martin Cederlöf; Brian M D'Onofrio; Catarina Almqvist; Henrik Larsson; Paul Lichtenstein
Journal:  JAMA Psychiatry       Date:  2017-08-01       Impact factor: 21.596

Review 7.  Attention-Deficit/Hyperactivity Disorder (ADHD) and Emotion Regulation Over the Life Span.

Authors:  Hanna Christiansen; Oliver Hirsch; Björn Albrecht; Mira-Lynn Chavanon
Journal:  Curr Psychiatry Rep       Date:  2019-03-02       Impact factor: 5.285

8.  Pharmacist Medication Management of Adults with Attention Deficit: An Alternative Clinical Structure.

Authors:  Rex Huang; Samuel J Ridout; Brooke Harris; Kathryn K Ridout; Kavitha Raja
Journal:  Perm J       Date:  2020-03-18

9.  The Association Between Insomnia and Sleep Duration in Adults With Attention-Deficit Hyperactivity Disorder: Results From a General Population Study.

Authors:  Dora Wynchank; Margreet Ten Have; Denise Bijlenga; Brenda W Penninx; Aartjan T Beekman; Femke Lamers; Ron de Graaf; J J Sandra Kooij
Journal:  J Clin Sleep Med       Date:  2018-03-15       Impact factor: 4.062

Review 10.  Treatment for Substance Use Disorder With Co-Occurring Mental Illness.

Authors:  Muhammad N Iqbal; Charles J Levin; Frances R Levin
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.